-
-
Editor's Choice -
Pharma & Human Health -
Editor's Choice -
Finance
Editor’s Choice
Editor's Choice
Mental Health and the Brain-Gut-Microbiota Axis: Fundamental Importance of Diet
The Mediterranean diet is regarded as the most beneficial diet from a mental health perspective. The benefits of such a diet are mediated significantly through the brain- gut-microbiota axis. Abnormalities in this axis have been described in the most […]
Editor's Choice
Novel In vitro Model Replicates Intestinal Microbiota Composition Without Requiring Anaerobic Incubation
The majority of the gut microbiota is unculturable using standard laboratory techniques, which has been well-documented since the advent of next generation sequencing in microbiome research. This limitation makes it difficult to characterise the phenotype […]
Editor's Choice
Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
With bacterial strains of the same species exhibiting remarkably different characteristics, it is vital biotic developers accurately characterise what strains are present in their product. This enables developers to maximise the biotics’ therapeutic potential, provide […]
In Case you Missed it:
Pharma & Human Health
Bloom Science Demonstrates Durable Weight Loss in Overweight Individuals in Phase 1 Trial of BL-001
Bloom Science, Inc., a clinical-stage biotech company focused on the development of novel therapies for metabolic and neurological disorders, today announced that BL-001, an investigational oral therapy designed to replicate the positive effects of the ketogenic […]
Editor's Choice
Dynamic Microbiome Abundance Profiling: A new tool to solve challenges in microbiome analysis
With bacterial strains of the same species exhibiting remarkably different characteristics, it is vital biotic developers accurately characterise what strains are present in their product. This enables developers to maximise the biotics’ therapeutic potential, provide […]
Pharma & Human Health
Synthetic microbiome therapy suppresses bacterial infection without antibiotics
A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously difficult-to-treat and potentially life threatening in humans, according to a team of researchers at Penn State. The […]
Finance
BiomX Announces a Series of Financings for Aggregate Gross Proceeds of $12 Million
BiomX Inc. (NYSE American: PHGE, the “Company” or “BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced that it has entered into a securities purchase agreement […]
Editor's Choice
Scientists decode diet from stool DNA – no questions asked
Scientists have developed a breakthrough method to track diet using stool metagenomic data. Developed by researchers at the Institute for Systems Biology (ISB), the new method, called MEDI (Metagenomic Estimation of Dietary Intake), detects food-derived […]
Editor's Choice
Hervé Affagard talks Phase 3 results, the regulatory landscape and industry collaborations
In early January MaaT Pharma made waves in the pharma world with the announcement of positive topline results for their phase 3 trial of MaaT013 in acute Graft-versus-Host Disease. With robust efficacy and safety data, […]
Pharma & Human Health
Global “sisterhood” seeks to understand what makes a healthy vaginal microbiome
Vaginas host a complex microcosm of bacteria and yeasts that can fluctuate over time. However, little is known about these microbial communities and their roles in a person’s health, and 9 out of 10 studies […]
Pharma & Human Health
Vedanta Biosciences Publishes Additional Phase 2 VE303 Results in Nature Medicine
Vedanta Biosciences today announced the publication of additional results from the Phase 2 CONSORTIUM study for its lead candidate, VE303, which is being evaluated for prevention of recurrent Clostridioides difficile infection (rCDI). The new analyses were published […]
